Endeavor Group Holdings, Inc.
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to firstname.lastname@example.org.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at email@example.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
1800 Century Park East, Suite 600
Los Angeles, CA 90067
The lawsuit claims that throughout the class period, the defendants made false and/or misleading statements and/or failed to disclose important information about the company’s financial state and the development of a drug called Motixafortide. Specifically, the lawsuit claims that the company did not have enough funding to develop the drug, that it would require a loan and securities offering to launch the drug, and that these factors made the company’s statements about its business, operations, and prospects misleading and without reasonable basis. As a result of these false statements, investors suffered damages.